May 27th 2022
In this installment of Urology Times' 50th Anniversary Innovation Celebration, Rachel S. Rubin, MD, discusses the evolution in the treatment of female hypoactive sexual desire disorder.
September 9th 2021
November 22nd 2019
September 9th 2019
Pilot study finds oral SERM improves pain and sexual functionJuly 11th 2018
An oral selective estrogen receptor modulator approved for treatment of mild to moderate dyspareunia in menopausal women reduced signs and symptoms of atrophy in the vulva, vestibule, urethral meatus and vagina region, according to results of a prospective open-label pilot study
Psychological costs and benefits of sexual motivation in couples dealing with vulvodyniaMay 15th 2018
Understanding the psychological underpinnings of sexual motivation can be helpful in improving the sexual and relationship well-being of couples affected by vulvodynia, according to recent research.
Rating scale criteria for sexual desire differ between clinician, patientMarch 6th 2018
In large part, clinicians and patients do not see eye to eye when it comes to what they consider important criteria for a rating scale assessing female sexual desire, according to a literature review
Sex hormones only part of the equation in modulating HSDDMarch 6th 2018
According to a literature review, apart from the essential role that sex hormones play in modulating hypoactive sexual desire disorder (HSDD) through therapeutic interventions, a comprehensive understanding of the biologic mechanisms underlying the disorder is imperative.
Flibanserin can cause weight loss in pre/postmenopausal women with HSDDFebruary 6th 2018
Premenopausal and postmenopausal women treated with the combined agonist/antagonist flibanserin for hypoactive sexual desire disorder (HSDD) are likely to lose weight, according to a post hoc analysis of five studies.
Study: Fetal head station during OVD does not increase sexual dysfunction/postpartum depressionFebruary 6th 2018
Midpelvic attempted operative vaginal delivery (aOVD) does not increase risk of sexual dysfunction in women or their male partners nor are the women more likely to manifest symptoms of maternal postpartum depression at 6 months compared to counterparts who had low pelvic aOVD, according to a prospective study.
Detecting genital arousal much harder in women with arousal-specific sexual dysfunctionJanuary 22nd 2018
Women with arousal-specific sexual dysfunction are significantly less likely to perceive when their genitals are sexually aroused compared to women who have decreased sexual function or are sexually functional, according to an analysis of data from 5 studies
Talking to women about sexual dysfunction: Just do it!September 7th 2017
Female sexual dysfunction is not rare. In the United States, 44% of women are reported to experience some form of sexual dysfunction and 12% of these women report distress associated with dysfunction. Despite this high prevalence, many women never talk to their providers about their sexual difficulties or concerns and many providers fail to broach the topic with their patients.